Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD)
Note that you will be prompted to log in or register an account
Open BioLINCC Study See bottom of this webpage for request information
September 1995 - September 2005
Dataset(s) Last Updated
January 3, 2018
Clinical Trial URLs
Primary Publication URLs
Commercial Use Data Restrictions No
Data Restrictions Based On Area Of Research No
The objective of this study was to determine whether mortality and recurrent infarction are reduced by treatment of depression and LPSS with cognitive behavior therapy (CBT), supplemented with a selective serotonin reuptake inhibitor (SSRI) antidepressant when indicated, in patients enrolled within 28 days after MI.
Previous studies have proven that depression and low perceived social support (LPSS) after myocardial infarction (MI) are associated with higher morbidity and mortality, but little was known about whether this excess risk can be reduced through treatment.
The 2,481 MI patients (1,084 women and 1,397 men) were recruited from 73 hospitals affiliated with 8 clinical centers. All patients with an acute MI admitted to the participating hospitals were considered for enrollment. Exclusion criteria included patients with acute MI following percutaneous coronary intervention (PNI) or coronary artery bypass graft (CABG) surgery or those receiving psychotherapy for depression. Prior to April 1998, patients were excluded if they were taking any antidepressant medication and after April 1998 they were included if taking an antidepressant for longer than 14 days but remained depressed. Patients were also excluded if they had noncardiac conditions likely to be fatal within 1 year, were too ill to participate, were participating in another research protocol that posed a significant logistic burden or that might confound evaluation of the (ENRICHD) intervention, had major psychiatric comorbidity (including schizophrenia, bipolar disorder, severe dementia, or active substance abuse), were at imminent risk for suicide, refused to participate or their attending physician disallowed participation, could not be enrolled within 28 days of the acute event, or were inaccessible for intervention or follow-up.
The patients were diagnosed with major or minor depression by modified Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria and severity by the 17-item Hamilton Rating Scale for Depression (HRSD); LPSS was determined by the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Social Support Instrument (ESSI). Patients were randomly assigned to usual medical care or CBT-based psychosocial intervention. Cognitive behavior therapy was initiated at a median of 17 days after the index MI for a median of 11 individual sessions throughout 6 months, plus group therapy when feasible, with SSRIs for patients scoring higher than 24 on the HRSD or having a less than 50% reduction in Beck Depression Inventory scores after 5 weeks.
The intervention did not increase event-free survival. However, the intervention improved depression and social isolation, although the relative improvement in the psychosocial intervention group compared with the usual care group was less than expected due to substantial improvement in usual care patients.
Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N, for the ENRICHD Investigators. Effects of Treating Depression and Low Perceived Social Support on Clinical Events After Myocardial Infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003;289:3106-3116.
Please note that researchers must be registered on this site to submit a request, and you will be prompted to log in. If you are not registered on this site, you can do so via the Request button. Registration is quick, easy and free.
Resources AvailableStudy Datasets Only
- Data Dictionary (PDF - 906.4 KB)
- Protocol (PDF - 1.0 MB)
- Publications (PDF - 23.2 KB)
- Volume 1 Manual of Procedures (PDF - 1.1 MB)
- Volume 2 Manual of Procedures (PDF - 1.2 MB)
Persons using assistive technology may not be able to fully access information in the study documents. For assistance, Contact BioLINCC and include the web address and/or publication title in your message. If you need help accessing information in different file formats such as PDF, XLS, DOC, see Instructions for Downloading Viewers and Players.